Fonds de solidarité FTQ, TVM and Synta team up to form PRCL Research
Fonds de solidarité des travailleurs du Québec FTQ has joined with TVM Capital Life Science and U.S.-based Synta Pharmaceuticals Corp to invest in the establishment of PRCL Research Inc. The investment's value was not disclosed. Based in Montréal, PRCL Research is a special purpose company that develops pharmaceutical assets from the pre-clinical stage up to human proof-of-concept in single asset entities. Funding proceeds will be used to support its development with Synta of an oral treatment for psoriasis based on molecules developed by Synta and licensed to PRCL. Headquartered in Montréal, Fonds de solidarité FTQ invests growth capital in companies primarily located in Québec.
22 May 2014•3 mins read
